These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4404856)

  • 1. Nicotinamide inhibition of 3',5'-cyclic AMP phosphodiesterase in vitro.
    Shimoyama M; Kawai M; Hoshi Y; Ueda I
    Biochem Biophys Res Commun; 1972 Nov; 49(4):1137-41. PubMed ID: 4404856
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver.
    Hoshi Y
    Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
    Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
    Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the activity of liver NADase in rats after administration of nicotinic acid, 3-methylpyridine and nicotinamide in excess].
    Chagovets RV; Khalmuradov AG; Shushevich SI
    Dokl Akad Nauk SSSR; 1968 Jul; 181(1):245-7. PubMed ID: 4315740
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of NAD, nicotinamide and nicotinic acid on cyclic AMP accumulation by fat cells.
    Moreno FJ; Shepherd RE; Fain JN
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):179-83. PubMed ID: 221845
    [No Abstract]   [Full Text] [Related]  

  • 6. A new assay of cyclic nucleotide phosphodiesterase; its application to human serum.
    Hidaka H; Shibuya M
    Biochem Med; 1974 Aug; 10(4):301-11. PubMed ID: 4368336
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple forms of cyclic 3',5'-AMP phosphodiesterase of rat cerebrum and cloned astrocytoma and neuroblastoma cells.
    Uzunov P; Shein HM; Weiss B
    Neuropharmacology; 1974 May; 13(5):377-91. PubMed ID: 4370207
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of nicotinic acid and some of its homologues on lipolysis, adenyl cyclase, phosphodiesterase and cyclic AMP accumulation in isolated fat cells.
    Skidmore IF; Schönhöfer PS; Kritchevsky D
    Pharmacology; 1971; 6(6):330-8. PubMed ID: 4338398
    [No Abstract]   [Full Text] [Related]  

  • 9. 1-Ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)--a potent new inhibitor of cyclic 3',5'-nucleotide phosphodiesterases.
    Chasin M; Harris DN; Phillips MB; Hess SM
    Biochem Pharmacol; 1972 Sep; 21(18):2443-50. PubMed ID: 4345859
    [No Abstract]   [Full Text] [Related]  

  • 10. Assay of phosphodiesterase with radioactively labeled cyclic 3',5'-AMP as substrate.
    Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):272-99. PubMed ID: 4337726
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of nicotinamide and homologs on the activity of inducible enzymes and NAD content of the rat liver.
    Blake RL; Blake SL; Loh HH; Kun E
    Mol Pharmacol; 1967 Sep; 3(5):412-22. PubMed ID: 4383205
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphodiesterase in the liver fluke, Fasciola hepatica.
    Mansour TE; Mansour JM
    Biochem Pharmacol; 1977 Dec; 26(24):2325-30. PubMed ID: 202282
    [No Abstract]   [Full Text] [Related]  

  • 13. On the role of 3',5'-cyclic amp phosphodiesterase in insulin action on rat liver and adipose tissue.
    Hepp D; Menahan A; Wieland O
    Horm Metab Res; 1969 Mar; 1(2):93-4. PubMed ID: 4334869
    [No Abstract]   [Full Text] [Related]  

  • 14. Competitive inhibition of beef heart cyclic AMP phosphodiesterase by cytokinins and related compounds.
    Hecht SM; Faulkner RD; Hawrelak SD
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4670-4. PubMed ID: 4373727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase-a possible mechanism of action of bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):211-7. PubMed ID: 163094
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interaction of muscle glycogen phosphorylase b with nicotinic acid, nicotinamide, N-nicotinyl-gamma-aminobutyric acid and nicotinamide coenzymes].
    Klinova NI; Chebotareva NA; Klinov SV; Kurganov BI; Bulanova LN
    Bioorg Khim; 1987 Oct; 13(10):1338-43. PubMed ID: 2963642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP and phosphodiesterase in synaptic vesicles from mouse brain.
    Johnson GA; Boukma SJ; Lahti RA; Mathews J
    J Neurochem; 1973 May; 20(5):1387-92. PubMed ID: 4352033
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase activity by diuretics and other agents.
    Gadd RE; Clayman S; Hébert D
    Experientia; 1973 Oct; 29(10):1217-9. PubMed ID: 4357188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of nicotinic acid and nicotinamide on the activity of NADPH- and NADH-dependent redox chains in rat liver endoplasmic reticulum].
    Lukienko PI; Bushma MI
    Farmakol Toksikol; 1982; 45(2):78-81. PubMed ID: 6210571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin PP, nicotinamide nucleotides and neuro-muscular transmission in guinea pig cecum longitudinal muscle (taenia coli)].
    Romanenko AV
    Ukr Biokhim Zh (1978); 1980; 52(5):624-7. PubMed ID: 6455000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.